Publications by authors named "Sandro Pignata"

100Publications

How to sequence treatment in relapsed ovarian cancer.

Future Oncol 2020 Dec 23. Epub 2020 Dec 23.

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.

View Article and Find Full Text PDF
December 2020

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.

Ther Adv Med Oncol 2020 2;12:1758835920968463. Epub 2020 Nov 2.

Medical Oncology Unit, University Hospital of Parma, Parma, Italy.

View Article and Find Full Text PDF
November 2020

Therapeutic options following second-line platinum-based chemotherapy in patients with recurrent ovarian cancer: Comparison of active surveillance and maintenance treatment.

Cancer Treat Rev 2020 Nov 21;90:102107. Epub 2020 Sep 21.

Department of Gynecology and Gynecological Oncology, Evangelische Kliniken Essen-Mitte (KEM), Essen, Germany. Electronic address:

View Article and Find Full Text PDF
November 2020

Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.

Authors:
Margaret Ottaviano Marcello Curvietto Pasquale Rescigno Marianna Tortora Giovannella Palmieri Diana Giannarelli Michele Aieta Pasquale Assalone Laura Attademo Antonio Avallone Francesco Bloise Davide Bosso Valentina Borzillo Giuseppe Buono Giuseppe Calderoni Francesca Caputo Giacomo Cartenì Diletta Cavallero Alessia Cavo Fortunato Ciardiello Raffaele Conca Vincenza Conteduca Stefano De Falco Marco De Felice Michelino De Laurentiis Pietro De Placido Sabino De Placido Irene De Santo Alfonso De Stefano Carminia Maria Della Corte Rossella Di Franco Vincenzo Di Lauro Antonietta Fabbrocini Piera Federico Lucia Festino Pasqualina Giordano Mario Giuliano Cesare Gridelli Antonio Maria Grimaldi Michela Lia Antonella Lucia Marretta Valentina Massa Alessia Mennitto Sara Merler Valeria Merz Carlo Messina Marco Messina Monica Milano Alessandro Marco Minisini Vincenzo Montesarchio Alessandro Morabito Floriana Morgillo Brigitta Mucci Lucia Nappi Fabiana Napolitano Immacolata Paciolla Martina Pagliuca Giuseppe Palmieri Sara Parola Stefano Pepe Angelica Petrillo Francovito Piantedosi Luisa Piccin Fernanda Picozzi Erica Pietroluongo Sandro Pignata Veronica Prati Vittorio Riccio Mario Rosanova Alice Rossi Anna Russo Massimiliano Salati Giuseppe Santabarbara Andrea Sbrana Ester Simeone Antonia Silvestri Massimiliano Spada Paolo Tarantino Paola Taveggia Federica Tomei Tortora Vincenzo Dario Trapani Claudia Trojanello Vito Vanella Sabrina Vari Jole Ventriglia Maria Grazia Vitale Fabiana Vitiello Caterina Vivaldi Claudia von Arx Francesca Zacchi Ilaria Zampiva Andrea Zivi Bruno Daniele Paolo Antonio Ascierto

J Immunother Cancer 2020 10;8(2)

Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Campania, Italy

View Article and Find Full Text PDF
October 2020

Immunotherapy in cervix cancer.

Cancer Treat Rev 2020 Nov 7;90:102088. Epub 2020 Aug 7.

Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli, Italy. Electronic address:

View Article and Find Full Text PDF
November 2020

Cytological diagnosis of Xp11 translocation renal cell carcinoma: An unusual suspect in bone metastases from unknown primary malignancies.

Diagn Cytopathol 2021 Jan 18;49(1):11-17. Epub 2020 Aug 18.

Pathology Unit, Department of Mental and Physical Health and Preventive Medicine, Università della Campania "Luigi Vanvitelli", Naples, Italy.

View Article and Find Full Text PDF
January 2021

PARP Inhibitors in First-Line Therapy of Ovarian Cancer: Are There Any Doubts?

Front Oncol 2020 12;10:782. Epub 2020 Jun 12.

Division of Medical Oncology, Department of Precision Medicine, School of Medicine, "Luigi Vanvitelli" University of Campania, Naples, Italy.

View Article and Find Full Text PDF
June 2020

Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

J Clin Med 2020 Jun 3;9(6). Epub 2020 Jun 3.

Department of Maternal and Child Health and Urological Sciences, University of Rome "Sapienza", Policlinico "Umberto I", 00161 Rome, Italy.

View Article and Find Full Text PDF
June 2020

Incorporating Parp-inhibitors in Primary and Recurrent Ovarian Cancer: A Meta-analysis of 12 phase II/III randomized controlled trials.

Cancer Treat Rev 2020 Jul 26;87:102040. Epub 2020 May 26.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Gynaecology, European Competence Center for Ovarian Cancer, Campus Virchow Clinic, 13353 Berlin, Germany.

View Article and Find Full Text PDF
July 2020

Treatment of recurrent epithelial ovarian cancer.

Cancer 2019 Dec;125 Suppl 24:4609-4615

Department of Urogynecology, National Cancer Institute, Pascale Foundation (Scientific Institute for Research and Healthcare), Naples, Italy.

View Article and Find Full Text PDF
December 2019

Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.

N Engl J Med 2019 12;381(25):2416-2428

From Centre Léon Bérard (I.R.-C., D.P.), University Claude Bernard Lyon 1 (I.R.-C.), and Centre Hospitalier Lyon-Sud (B.Y.), Lyon, Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens (GINECO) (I.R.-C., P.P., F.S., C.L.-P., A.L., P.C., M.R., C.D., B.Y., E.P.-L.), Groupe Hospitalier Diaconesses Croix Saint-Simon (F.S.), Hôpital Européen Georges Pompidou (P.C.), Institut Curie, Hôpital Claudius Régaud (M.R.), and Association de Recherche Cancers Gynécologiques (ARCAGY) (E.P.-L.), Paris, Gustave Roussy, Villejuif (P.P.), Centre Eugène Marquis, Rennes (C.L.-P.), Centre Catherine de Sienne Hôpital Privé du Confluent, Nantes (A.L.), and Institut Curie, Hôpital René Huguenin, Saint Cloud (C.D.) - all in France; the Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, and Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples (S.P.), University of Milan-Bicocca and European Institute of Oncology IRCCS, and Mario Negri Gynecologic Oncology Group (MANGO) (N.C.), and Fondazione IRCCS Istituto Nazionale Tumori and MITO (D.L.), Milan, and Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica, and MITO, Rome (G.S.) - all in Italy; M.D. Anderson Cancer Center Madrid (A.G.-M.), Grupo Español de Investigación en Cáncer de Ovario (GEICO) (A.G.-M., E.M.G.A.), and Hospital Universitario Ramón y Cajal (E.M.G.A.) - all in Madrid; Medical University of Innsbruck, University Clinic for Gynecology and Obstetrics (R.B.), and Arbeitsgemeinschaft Gynäkologische Onkologie Study Group (AGO)-Austria (R.B., A.R.), Innsbruck, and Medical University of Vienna, Vienna (A.R.) - all in Austria; Saitama Medical University International Medical Center, Hidaka (K.F.), Gynecologic Oncology Trial and Investigation Consortium (GOTIC), Moroyama-cho (K.F., S.N.), and Hyogo Cancer Center, Akashi (S.N.) - all in Japan; University Hospital Leuven, Leuven Cancer Institute, and Belgium and Luxembourg Gynecologic Oncology Group (BGOG) - both in Leuven, Belgium (I.V.); Tampere University and University Hospital, Tampere, Finland (J.M.); the Nordic Society of Gynecologic Oncology (NSGO), Copenhagen (J.M.); and Charité-Medical University of Berlin (Campus Virchow Klinikum), Berlin (J.S.), German Society of Gynecologic Oncology (AGO) (J.S., U.C., F.M., N.G., P.B., A.B., P.H.), Universitätsklinikum Essen (P.B.), and Kliniken Essen Mitte (P.H.), Essen, Universitätsklinikum Carl Gustav Carus, Technische Universität Dresden, Dresden (U.C.), Universitätsklinikum Heidelberg, Heidelberg (F.M.), Universitätsklinikum Ulm, Ulm (N.G.), and Klinikum der Universität München, Munich (A.B.) - all in Germany.

View Article and Find Full Text PDF
December 2019

Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for Testing.

J Clin Oncol 2020 01 7;38(2):172-173. Epub 2019 Nov 7.

Alberto Farolfi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy; Domenica Lorusso, MD, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Rome, Italy; Sandro Pignata, MD, PhD, Istituto Nazionale Tumori, IRCCS, Fondazione G. Pascale, Naples, Italy; and Ugo De Giorgi, MD, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, IRCCS, Meldola, Italy.

View Article and Find Full Text PDF
January 2020

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors.

Cancers (Basel) 2019 Oct 17;11(10). Epub 2019 Oct 17.

Department of Obstetrics and Gynaecology, San Raffaele Scientific Institute, 20132 Milan, Italy.

View Article and Find Full Text PDF
October 2019

Management of Platinum-Resistant, Relapsed Epithelial Ovarian Cancer and New Drug Perspectives.

J Clin Oncol 2019 09 12;37(27):2437-2448. Epub 2019 Aug 12.

Istituto Nazionale Tumori Fondazione G Pascale, Istituto di Ricovero e Cura a Carattere Scientifico, Napoli, Italy.

View Article and Find Full Text PDF
September 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Gynecol Oncol 2019 08;154(2):255-258

GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA.

View Article and Find Full Text PDF
August 2019

Joint ENGOT and GOG Foundation requirements for trials with industry partners.

Int J Gynecol Cancer 2019 09 18;29(7):1094-1097. Epub 2019 Jul 18.

GOG-F and Gynecologic Oncology, Ohio State University Wexner Medical Center and JamesCare Gynecologic Oncology at Mill Run, Columbus, Ohio, USA.

View Article and Find Full Text PDF
September 2019

PARP inhibitors in ovarian cancer.

Cancer Treat Rev 2019 Feb 4;73:1-9. Epub 2018 Dec 4.

Division of Medical Oncology, Department of Precision Medicine, School of Medicine, "Luigi Vanvitelli" University of Campania, 80131 Naples, Italy.

View Article and Find Full Text PDF
February 2019

Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer.

J Clin Oncol 2018 05 20;36(13):1300-1307. Epub 2018 Mar 20.

Nicoletta Colombo, University of Milan-Bicocca; Nicoletta Colombo, Istituto Europeo di Oncologia, Milan; Giovanni Scambia, Università Cattolica del Sacro Cuore di Roma, Rome; Sandro Pignata, Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G Pascale IRCCS, Naples, Italy; Gloria Huang, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx; Eva Chalas, Winthrop University Hospital, Mineola, NY; James Fiorica, Sarasota Memorial Hospital, Sarasota, FL; Linda Van Le, University of North Carolina School of Medicine, Chapel Hill, NC; Sharad Ghamande, The Georgia Cancer Center at Augusta University, Augusta; Andrew Green, Northeast Georgia Medical Center, Gainesville, GA; Santiago González-Santiago, Hospital San Pedro de Alcántara, Cáceres; Isabel Bover, Hospital Son Llàtzer, Palma; Begoña Graña Suárez, University Hospital A Coruña, Sergas, Spain; Philippe Huot-Marchand and Yann Bourhis, Mapi Real World Evidence, Lyon, France; Sudeep Karve, AstraZeneca, Gaithersburg, MD; and Christopher Blakeley, AstraZeneca, Cambridge, United Kingdom.

View Article and Find Full Text PDF
May 2018

Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016.

J Transl Med 2017 10 11;15(1):205. Epub 2017 Oct 11.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", Naples, Italy.

View Article and Find Full Text PDF
October 2017

Randomized Controlled Trial Testing the Efficacy of Platinum-Free Interval Prolongation in Advanced Ovarian Cancer: The MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG Study.

J Clin Oncol 2017 Oct 21;35(29):3347-3353. Epub 2017 Aug 21.

Sandro Pignata, Carmela Pisano, Sabrina Chiara Cecere, Marilena Di Napoli, Laura Arenare, Alice Bergamini, Jane Bryce, Gennaro Daniele, Maria Carmela Piccirillo, and Francesco Perrone, Istituto Nazionale per lo Studio e la Cura dei Tumori-Fondazione G. Pascale, IRCCS; Simona Signoriello and Ciro Gallo, Università degli Studi della Campania Luigi Vanvitelli, Naples; Giovanni Scambia, Domenica Lorusso, Gabriella Ferrandina, and Vanda Salutari, Università Cattolica del Sacro Cuore; Enrico Breda, Ospedale San Giovanni Calibita Fatebenefratelli, Rome; Alessandra Bologna, Azienda Ospedaliea Santa Maria Nuova, IRCCS, Reggio Emilia; Domenica Lorusso and Francesco Raspagliesi, Fondazione IRCCS Istituto Nazionale dei Tumori; Giorgia Mangili and Alice Bergamini, Ospedale San Raffaele, Milan; Viviana Murgia, Ospedale Santa Chiara, Trento; Roberto Sorio, Centro di Riferimento Oncologico, Aviano; Gabriella Ferrandina, Centro di Ricerca e Formazione Ad Alta Tecnologia nelle Scienze Biomediche, Università Cattolica del Sacro Cuore, Campobasso; Cosimo Sacco, Azienda Ospedaliera di Perugia Santa Maria della Misericordia, Udine; Gennaro Cormio, Ginecologia Oncologica, Università di Bari e Istituto Oncologico "Giovanni Paolo II" Bari; Saverio Cinieri, Ospedale Antonio Perrino, Brindisi; Donato Natale, Ospedale San Massimo, Penne, Italy; Ignace B. Vergote, University Hospital Leuven and Belgian and Luxembourg Gynaecological Oncology Group, Leuven Cancer Institute, Leuven, Belgium; and Uwe Wagner, Uniklinkum Giessen und Marburg Gynäkologie, Marburg, Germany.

View Article and Find Full Text PDF
October 2017

Immunotherapy in ovarian, endometrial and cervical cancer: State of the art and future perspectives.

Cancer Treat Rev 2017 Sep 31;59:109-116. Epub 2017 Jul 31.

Division of Medical Oncology, Department of Uro-Gynaecological Oncology, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", Naples, Italy.

View Article and Find Full Text PDF
September 2017

Obesity and Cancer: Biological Links and Treatment Implications.

Curr Cancer Drug Targets 2018 ;18(3):231-238

Istituto Nazionale Tumori di Napoli, "G. Pascale" foundation, Department of Abdominal Oncology, via M. Semmola, 80131, Naples, Italy.

View Article and Find Full Text PDF
April 2019

A miRNA signature assessing ovarian cancer prognosis.

Oncoscience 2016 2;3(11-12):308-310. Epub 2016 Dec 2.

Molecular Therapies Unit, Dept of Experimental Oncology and Molecular Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Milan, Italy.

View Article and Find Full Text PDF
December 2016

Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: the prospective observational scoop trial results.

Anticancer Drugs 2017 01;28(1):104-109

aDivision of Medical Oncology, Department of Uro-Gynaecological Oncology 'Istituto Nazionale Tumori' 'Fondazione G. Pascale'-IRCCS bUnit of Epidemiology, 'Istituto Nazionale Tumori' 'Fondazione G. Pascale' - IRCCS cDivision of Medical Oncology, 'San Gennaro dei Poveri' Hospital, Naples dDepartment of Onco-Ematology and Medical Oncology, S.G. Moscati Hospital of Taranto, Taranto eDivision of Medical Oncology, 'San Giuseppe Moscati' Hospital, Avellino fDivision of Medical Oncology, 'Gaetano Rummo' Hospital, Benevento gDepartment of Medical Oncology, National Cancer Institute, Aviano, Italy.

View Article and Find Full Text PDF
January 2017

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma: JGOG3017/GCIG Trial.

J Clin Oncol 2016 08 11;34(24):2881-7. Epub 2016 Jul 11.

Toru Sugiyama, Iwate Medical University, Iwate; Aikou Okamoto, Hiroshi Tanabe, and Seiji Isonishi, The Jikei University School of Medicine; Tetsutaro Hamano, Kitasato University; Yasuhisa Terao, Juntendo University; Mikio Mikami, Tokai University; Hiroyuki Nomura and Daisuke Aoki, Keio University; Fumitoshi Terauchi, Tokyo Medical University, Tokyo; Takayuki Enomoto and Koji Nishino, Niigata University, Niigata; Eriko Aotani, Kanagawa Academy of Science and Technology; Nao Suzuki, St Marianna University, Kanagawa; Nobuo Yaegashi, Tohoku University, Miyagi; Kiyoko Kato, Kyushu University, Fukuoka; Hiroyuki Yoshikawa, University of Tsukuba, Ibaraki; Yoshihito Yokoyama, Hirosaki University, Aomori; Keiichi Fujiwara, Saitama Medical University International Medical Center, Saitama, Japan; Jae-Weon Kim, Seoul National University; Byoung-Gie Kim, Sungkyunkwan University, Seoul, South Korea; Sandro Pignata, Istituto Nazionale Tumori di Napoli, Naples, Italy; Jerome Alexandre, Hôpital Hôtel-Dieu, Montreal, Quebec, Canada; and John Green, University of Liverpool, Liverpool, United Kingdom.

View Article and Find Full Text PDF
August 2016

Tumor genotype and immune microenvironment in POLE-ultramutated and MSI-hypermutated Endometrial Cancers: New candidates for checkpoint blockade immunotherapy?

Cancer Treat Rev 2016 Jul 18;48:61-8. Epub 2016 Jun 18.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Via Mariano Semmola 52, 80131 Naples, Italy. Electronic address:

View Article and Find Full Text PDF
July 2016

Bevacizumab in ovarian cancer: Focus on clinical data and future perspectives.

Crit Rev Oncol Hematol 2016 Jan 10;97:335-48. Epub 2015 Aug 10.

Policlinico Universitario A. Gemelli, Rome, Italy. Electronic address:

View Article and Find Full Text PDF
January 2016

Randomized Phase II Trial of Ridaforolimus in Advanced Endometrial Carcinoma.

J Clin Oncol 2015 Nov 15;33(31):3576-82. Epub 2015 Jun 15.

Amit M. Oza, Princess Margaret Cancer Centre, Toronto, ON, Canada; Sandro Pignata, Istituto Nazionale Tumori "Fondazione G Pascale"-Istituto Di Ricovero e Cura a Carattere Scientifico, Naples, Italy; Andres Poveda, Instituto Valenciano de Oncologia, Valencia, Spain; Mary McCormack, University College Hospital, London; Andrew Clamp, Institute of Cancer Sciences-University of Manchester and the Christie National Health Service Foundation Trust, Manchester, United Kingdom; Benjamin Schwartz, Island Gynecologic Oncology, Brightwaters, NY; Jonathan Cheng, Xiaoyun Li, and Kristy Campbell, Merck, Kenilworth, NJ; and Pierre Dodion and Frank G. Haluska, ARIAD Pharmaceuticals, Cambridge, MA.

View Article and Find Full Text PDF
November 2015

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.

Sci Rep 2015 May 28;5:10357. Epub 2015 May 28.

Molecular Immunology and Immuneregulation, Istituto Nazionale per lo Studio e la Cura dei Tumori "Fondazione Giovanni Pascale" IRCCS-ITALIA. Via Mariano Semmola 80131, Naples, Italy.

View Article and Find Full Text PDF
May 2015

Low Grade Serous Ovarian Carcinoma: from the molecular characterization to the best therapeutic strategy.

Cancer Treat Rev 2015 Feb 23;41(2):136-43. Epub 2014 Dec 23.

Department of Urology and Gynecology, Istituto Nazionale Tumori "Fondazione G. Pascale", IRCCS, Via Mariano Semmola, 52, 80131 Naples, Italy.

View Article and Find Full Text PDF
February 2015

Gynecologic Cancer InterGroup (GCIG) consensus review for cervical adenocarcinoma.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S96-101

*Jichi Medical University, Shimono-City, Japan and GOTIC; †Saitama Cancer Center, Saitama-City, Japan and GOTIC; ‡University of Arizona, Phoenix, AZ and GOG; §Centre Leon Berard, Lyon, France and GINECO; ∥Hospices Civils de Lyon, Lyon, France and GINECO; ¶The Canberra Hospital, Canberra, Australia and ANZGOG; #Seoul National University College of Medicine, Seoul, Korea and KGOG; **Universtatsklinikum Hamburg-Eppendorf, Hamburg, Germany and AGO; ††Walter Reed National Military Medical Center, Bethesda, MD and GOG; ‡‡Istituto Nazionale Tumori "Fondazione G. Pascale" - IRCCS, Milan, Italy and MITO; and §§Saitama Medical University International Medical Center, Hidaka-City, Japan and GOTIC.

View Article and Find Full Text PDF
November 2014

Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian and primary peritoneal low-grade serous carcinomas.

Int J Gynecol Cancer 2014 Nov;24(9 Suppl 3):S9-13

*University of Edinburgh Cancer Research UK Centre, MRC IGMM, Edinburgh, United Kingdom; †Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Creighton University School of Medicine at St Joseph's Hospital and Medical Center, Phoenix, AZ; ‡Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montreal, Quebec, Canada, Division of Gynecologic Oncology, Université de Montréal, Montreal, Quebec, Canada; §Dipartimento di Oncologia Uroginecologica, Istituto Nazionale per lo Studio e la Cura dei Tumori, Fondazione G Pascale, IRCCS, Napoli, Italy; ∥Division of Cancer Medicine, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia; ¶Department of Gynecology and Gynecologic Oncology, Kliniken Essen-Mitte, Essen, Germany; #Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland; **Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea; ††Université Paris Descartes, Assistance Publique-Hôpitaux de Paris, Paris, France; ‡‡The Beatson West of Scotland Cancer Centre, Gartnavel Hospital, University of Glasgow, Glasgow, United Kingdom; §§Département d'Oncologie médicale adulte, Centre Léon Bérard, Lyon, France; and ∥∥Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article and Find Full Text PDF
November 2014